Cargando…
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies
Cholangiocarcinoma (CC) encompasses a group of related but distinct malignancies whose lack of a stereotyped genetic signature makes challenging the identification of genomic landscape and the development of effective targeted therapies. Accumulated evidences strongly suggest that the remarkable gen...
Autores principales: | Brandi, Giovanni, Farioli, Andrea, Astolfi, Annalisa, Biasco, Guido, Tavolari, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558112/ https://www.ncbi.nlm.nih.gov/pubmed/26142706 |
Ejemplares similares
-
Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020) -
Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review
por: Tavolari, Simona, et al.
Publicado: (2023) -
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures
por: Rizzo, Alessandro, et al.
Publicado: (2020) -
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis
por: Brandi, Giovanni, et al.
Publicado: (2013) -
Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link
por: Brandi, Giovanni, et al.
Publicado: (2022)